These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37343519)

  • 101. An overview of menopause associated vasomotor symptoms and options available in its management.
    Okeke TC; Ezenyeaku CC; Ikeako LC; Agu PU
    Niger J Med; 2013; 22(1):7-14. PubMed ID: 23441513
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.
    Bouchard P; Panay N; de Villiers TJ; Vincendon P; Bao W; Cheng RJ; Constantine G
    Climacteric; 2012 Feb; 15(1):12-20. PubMed ID: 22066790
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial.
    Geller SE; Shulman LP; van Breemen RB; Banuvar S; Zhou Y; Epstein G; Hedayat S; Nikolic D; Krause EC; Piersen CE; Bolton JL; Pauli GF; Farnsworth NR
    Menopause; 2009; 16(6):1156-66. PubMed ID: 19609225
    [TBL] [Abstract][Full Text] [Related]  

  • 104. A randomized, double-blind, placebo-controlled trial of Chinese herbal medicine granules for the treatment of menopausal symptoms by stages.
    Fu SF; Zhao YQ; Ren M; Zhang JH; Wang YF; Han LF; Chang YX; Fan GW; Wang H; Huang YH; Zhai JB; Dong JY; Li X; Ai JQ; Zhang H; Zhu Y; Zhang BL; Sun LK; Fan X; Gao XM
    Menopause; 2016 Mar; 23(3):311-23. PubMed ID: 26671188
    [TBL] [Abstract][Full Text] [Related]  

  • 105. The effect of Hop (Humulus lupulus L.) on early menopausal symptoms and hot flashes: A randomized placebo-controlled trial.
    Aghamiri V; Mirghafourvand M; Mohammad-Alizadeh-Charandabi S; Nazemiyeh H
    Complement Ther Clin Pract; 2016 May; 23():130-5. PubMed ID: 25982391
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S; Komm BS
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Morning/evening menopausal formula relieves menopausal symptoms: a pilot study.
    Sun J
    J Altern Complement Med; 2003 Jun; 9(3):403-9. PubMed ID: 12816628
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Efficacy of a non-hormonal treatment, BRN-01, on menopausal hot flashes: a multicenter, randomized, double-blind, placebo-controlled trial.
    Colau JC; Vincent S; Marijnen P; Allaert FA
    Drugs R D; 2012 Sep; 12(3):107-19. PubMed ID: 22852580
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Fezolinetant findings can fuel future instrumentation inquiries.
    Carpenter JS
    Menopause; 2020 Dec; 27(12):1347. PubMed ID: 33048862
    [No Abstract]   [Full Text] [Related]  

  • 110. Treatment of menopausal vasomotor symptoms.
    Med Lett Drugs Ther; 2004 Dec 6-20; 47(1197-1198):98-9. PubMed ID: 15583526
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?
    Baerug U; Winge T; Nordland G; Faber-Swensson E; Heldaas K; Norling B; Larsen S; Arce JC
    Climacteric; 1998 Sep; 1(3):219-28. PubMed ID: 11907946
    [TBL] [Abstract][Full Text] [Related]  

  • 112. MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women.
    Stovall DW; Pinkerton JV
    Curr Opin Investig Drugs; 2009 Apr; 10(4):365-71. PubMed ID: 19337958
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Soybean isoflavones warrant greater consideration as a treatment for the alleviation of menopausal hot flashes.
    Messina M
    Womens Health (Lond); 2014 Nov; 10(6):549-53. PubMed ID: 25482479
    [No Abstract]   [Full Text] [Related]  

  • 114. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial.
    Butt DA; Lock M; Lewis JE; Ross S; Moineddin R
    Menopause; 2008; 15(2):310-8. PubMed ID: 17917611
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Vasomotor flushes in menopausal women.
    Bachmann GA
    Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 2):S312-6. PubMed ID: 10076170
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
    Speroff L; Gass M; Constantine G; Olivier S;
    Obstet Gynecol; 2008 Jan; 111(1):77-87. PubMed ID: 18165395
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Nonhormonal Therapies for Menopausal Vasomotor Symptoms.
    Christ JP; Navarro VM; Reed SD
    JAMA; 2023 Oct; 330(13):1278-1279. PubMed ID: 37713186
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Could menopause drug fezolinetant show promise for vasomotor symptoms associated with androgen deprivation therapy?
    Qin KR; Mertens E; Tempo JA; Perera M; Brennan J
    Transl Androl Urol; 2024 May; 13(5):920-922. PubMed ID: 38855582
    [No Abstract]   [Full Text] [Related]  

  • 119. Fezolinetant.
    Am J Health Syst Pharm; 2023 Aug; 80(17):1113-1114. PubMed ID: 37382493
    [No Abstract]   [Full Text] [Related]  

  • 120. Fezolinetant.
    Beninger P
    Clin Ther; 2023 Aug; 45(8):802-803. PubMed ID: 37442655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.